Welbiotech, Delay in Acquisition of Geumyoung ENG Shares
[Asia Economy Reporter Jang Hyowon] Wellbiotech announced on the 7th that it has corrected the payment date for the remaining balance of the contract to acquire 100% of Kumyoung ENG's shares for 35 billion KRW, originally set for November 6 this year, to January 14 next year. Accordingly, the payment date for the interim payment of 17.5 billion KRW has also been changed from that day to December 15.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- 2030s Prefer Temples, 5060s Choose Art Museums... Data Reveals Diverging Travel Preferences
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Kumyoung ENG is a company engaged in cleanroom machinery manufacturing and mechanical equipment construction. As of last year, it recorded sales of 50.2 billion KRW and a net profit of 3.7 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
